U.S. Lateral Flow Assay Market Size, Share, Trends, Industry Analysis Report, By Product (Kits & Reagents, Lateral Flow Readers, Benchtop Readers), By Application, By Technique, By End Use – Market Forecast, 2025–2034
Description
The U.S. lateral flow assay market size is expected to reach USD 5.39 billion by 2034, according to a new study by Polaris Market Research. The report “U.S. Lateral Flow Assay Market Size, Share, Trends, Industry Analysis Report By Product (Kits & Reagents, Lateral Flow Readers, Benchtop Readers), By Application, By Technique, By End Use – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
A lateral flow assay is a simple, paper-based diagnostic device used to detect the presence of a target substance, such as proteins, hormones, or pathogens, in a liquid sample.
The lateral flow assay application is expanding in noninfectious and nonclinical settings. While lateral flow assays were originally designed for infectious disease testing, they are now being used in a much wider range of applications. In healthcare, tests are being developed for conditions such as cancer, heart disease, and even neurological disorders. These tests can detect biomarkers related to disease risk or progression, helping doctors monitor patients more easily. Beyond medicine, LFAs are also used in veterinary care, food safety, and environmental monitoring. For example, they detect allergens in food or harmful bacteria in water. In agriculture, they help monitor animal health quickly on-site. This broad range of uses means that the demand for lateral flow tests is not limited to hospitals and clinics. As new applications are developed, particularly in industries that need fast results without lab access, lateral flow technology becomes even more important. This expansion into nontraditional settings drives the U.S. lateral flow assay market expansion.
The use of smartphones and digital readers is changing how lateral flow assays are interpreted and recorded. Instead of relying solely on human eyes to judge a faint line, digital readers and apps help provide more accurate and consistent results. Many of these tools read the test strip, interpret the result, and even store or transmit data directly to healthcare providers. This digital integration is particularly helpful in remote monitoring, telemedicine, and managing chronic conditions. For example, a patient can test at home and send the result to their doctor without needing to visit a clinic. These digital features also reduce the chances of misreading the result and improve data collection for public health tracking. As digital health becomes more common in the U.S., the ability to pair tests with smart technology makes lateral flow assays even more appealing, especially for patients who want fast answers with professional follow-up options.
U.S. Lateral Flow Assay Market Report Highlights
The kits & reagents segment dominated with the largest share in 2024 period as these components form the core of any lateral flow testing system and are directly responsible for carrying out the test and producing results.
The multiplex detection assays segment is expected to experience significant growth due to their ability to detect multiple targets simultaneously in a single test.
A few key players in the U.S. market are Abbott; Bio-Rad Laboratories, Inc; Siemens Healthineers AG; BIOMÉRIEUX; BD; QIAGEN; QuidelOrtho Corporation; F. Hoffmann-La Roche; DH Life Sciences, LLC; and Quest Diagnostics.
Polaris Market Research has segmented the U.S. lateral flow assay market report on the basis of product, application, technique, and end use:
By Product (Revenue – USD Billion, 2020–2034)
Kits & Reagents
Lateral Flow Readers
Benchtop Readers
Digital Readers
By Application (Revenue – USD Billion, 2020–2034)
Clinical Testing
Veterinary Diagnostics
Food Safety & Environment Testing
Drug Development & Quality Testing
By Technique (Revenue – USD Billion, 2020–2034)
Sandwich Assays
Competitive Assays
Multiplex Detection Assays
By End Use (Revenue – USD Billion, 2020–2034)
Hospitals & Clinics
Diagnostic Laboratories
Home Care
Pharmaceutical & Biotechnology Companies
Others
A lateral flow assay is a simple, paper-based diagnostic device used to detect the presence of a target substance, such as proteins, hormones, or pathogens, in a liquid sample.
The lateral flow assay application is expanding in noninfectious and nonclinical settings. While lateral flow assays were originally designed for infectious disease testing, they are now being used in a much wider range of applications. In healthcare, tests are being developed for conditions such as cancer, heart disease, and even neurological disorders. These tests can detect biomarkers related to disease risk or progression, helping doctors monitor patients more easily. Beyond medicine, LFAs are also used in veterinary care, food safety, and environmental monitoring. For example, they detect allergens in food or harmful bacteria in water. In agriculture, they help monitor animal health quickly on-site. This broad range of uses means that the demand for lateral flow tests is not limited to hospitals and clinics. As new applications are developed, particularly in industries that need fast results without lab access, lateral flow technology becomes even more important. This expansion into nontraditional settings drives the U.S. lateral flow assay market expansion.
The use of smartphones and digital readers is changing how lateral flow assays are interpreted and recorded. Instead of relying solely on human eyes to judge a faint line, digital readers and apps help provide more accurate and consistent results. Many of these tools read the test strip, interpret the result, and even store or transmit data directly to healthcare providers. This digital integration is particularly helpful in remote monitoring, telemedicine, and managing chronic conditions. For example, a patient can test at home and send the result to their doctor without needing to visit a clinic. These digital features also reduce the chances of misreading the result and improve data collection for public health tracking. As digital health becomes more common in the U.S., the ability to pair tests with smart technology makes lateral flow assays even more appealing, especially for patients who want fast answers with professional follow-up options.
U.S. Lateral Flow Assay Market Report Highlights
The kits & reagents segment dominated with the largest share in 2024 period as these components form the core of any lateral flow testing system and are directly responsible for carrying out the test and producing results.
The multiplex detection assays segment is expected to experience significant growth due to their ability to detect multiple targets simultaneously in a single test.
A few key players in the U.S. market are Abbott; Bio-Rad Laboratories, Inc; Siemens Healthineers AG; BIOMÉRIEUX; BD; QIAGEN; QuidelOrtho Corporation; F. Hoffmann-La Roche; DH Life Sciences, LLC; and Quest Diagnostics.
Polaris Market Research has segmented the U.S. lateral flow assay market report on the basis of product, application, technique, and end use:
By Product (Revenue – USD Billion, 2020–2034)
Kits & Reagents
Lateral Flow Readers
Benchtop Readers
Digital Readers
By Application (Revenue – USD Billion, 2020–2034)
Clinical Testing
Veterinary Diagnostics
Food Safety & Environment Testing
Drug Development & Quality Testing
By Technique (Revenue – USD Billion, 2020–2034)
Sandwich Assays
Competitive Assays
Multiplex Detection Assays
By End Use (Revenue – USD Billion, 2020–2034)
Hospitals & Clinics
Diagnostic Laboratories
Home Care
Pharmaceutical & Biotechnology Companies
Others
Table of Contents
129 Pages
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
